muscular dystrophy

A team led by clinical researchers from the Emory University School of Medicine has published a paper validating the use of RainDance Technologies' multiplexed PCR-based target enrichment technology upstream of a next-generation sequencing panel for comprehensive mutational analy

Benitec Biopharma this week announced that it has obtained positive in vitro data from its early-stage program in oculopharyngeal muscular dystrophy.

By Doug Macron
Benitec Biopharma last week broke out new details about its in-house pipeline, stating that it aims to have three drugs in clinical studies next year and possibly a fourth by 2014.

By Bernadette Toner
GenomeQuest this week said that the Emory Genetics Laboratory is using its GQ-Dx software to support a suite of sequencing-based diagnostic tests it offers through its CLIA-certified facility.

Quest will have the rights to develop and offer tests based on the technology in the US, India, and Mexico.

The sequencing will be done on ABI's SOLiD, and over the next three months Emory plans to add sequencing-based testing for mitochondrial diseases, prostate cancer, hearing loss, cardiomyopathy, and various types of mental retardation.

The French firm will use the grant to continue development of a molecular test for facio-scapulo-humeral dystrophy.

Pages

New results from the NASA Twins Study indicate that the immune system may rev up when in space, the Washington Post reports.

Kelvin Droegemeier, the new science advisor, spoke at the American Association for the Advancement of Science meeting, Geekwire reports.

In PNAS this week: whole-genome assembly for the white shark, paper-based microfluidic method for detecting the malaria parasite, and more.

The World Health Organization has announced the members of its gene-editing committee, according to NPR.